Enhancing in silico protein-based vaccine discovery for eukaryotic pathogens using predicted peptide-MHC binding and peptide conservation scores.
Given thousands of proteins constituting a eukaryotic pathogen, the principal objective for a high-throughput in silico vaccine discovery pipeline is to select those proteins worthy of laboratory validation. Accurate prediction of T-cell epitopes on protein antigens is one crucial piece of evidence...
Main Authors: | Stephen J Goodswen, Paul J Kennedy, John T Ellis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0115745 |
Similar Items
-
A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii
by: Stephen J. Goodswen, et al.
Published: (2023-05-01) -
Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research
by: Reinherz Ellis L, et al.
Published: (2008-12-01) -
Evaluating high-throughput ab initio gene finders to discover proteins encoded in eukaryotic pathogen genomes missed by laboratory techniques.
by: Stephen J Goodswen, et al.
Published: (2012-01-01) -
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
by: Reinherz Ellis L, et al.
Published: (2008-03-01) -
Discovery of conserved peptide-MHC epitopes for directly alloreactive CD8+ T cells
by: Alexandra E. Hill, et al.
Published: (2025-01-01)